Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Anticancer Res ; 42(12): 5743-5750, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36456148

ABSTRACT

BACKGROUND/AIM: We aimed to explore the role of intracellular C3 in pancreatic ductal adenocarcinoma (PDAC). MATERIALS AND METHODS: We evaluated C3 expression in PDAC using a gene expression database and tissue microarray. To clarify the role of C3 expression in PDAC, we conducted knockdown experiments using C3 short hairpin RNA (shRNA) in BxPC-3 cells. Differences in protein expression and cell behaviours were analysed. RESULTS: C3 was highly expressed in PDAC and correlated with cancer metastasis. In vitro experiments using BxPX-3 cells showed that C3 and its active form, C3a, were expressed in tumour cells. C3 knockdown reduced cell migration and invasion by inhibiting Akt/Smad pathway activation. TNF-α, not IL-6, enhanced C3 expression in this PDAC cell line. CONCLUSION: Intracellular C3 may regulate epithelial-mesenchymal transition in pancreatic cancer.


Subject(s)
Carcinoma, Pancreatic Ductal , Complement C3 , Epithelial-Mesenchymal Transition , Pancreatic Neoplasms , Humans , Carcinoma, Pancreatic Ductal/genetics , Pancreas , Pancreatic Neoplasms/genetics , Proto-Oncogene Proteins c-akt/genetics , RNA, Small Interfering , Complement C3/genetics , Smad Proteins , Cell Line, Tumor , Pancreatic Neoplasms
SELECTION OF CITATIONS
SEARCH DETAIL
...